The Conafay Group
Bryan Shuy has extensive work experience in government and healthcare. Bryan most recently served as Chief of Staff for a Member of Congress, and earlier held a high-ranking position with the US Department of Health and Human Services during the COVID-19 response. Bryan has also worked for various medical associations and government bodies in positions related to advocacy and policy. Prior to their work in government and healthcare, they worked as an insurance adjuster. Bryan will be assuming the position of Senior Vice President at The Conafay Group in 2023.
Bryan Shuy attended the University of Maryland from 2001 to 2005, where they earned a BA degree in the field of Government and Politics.
The Conafay Group
The Conafay Group works with life science companies and organizations to develop and implement government funding and public policy strategies. We also bridge ties to philanthropic, non-‐profit, academic and commercial entities to enhance client outcomes. Working on behalf of our clients, we create and execute dynamic strategies that facilitate: • Non-Dilutive Funding • Health Policy Advocacy • Ally Development • Federal Government Relations • Public-Private Partnerships • Federal Marketing • Coalition Management • Business-to-Business Partnering TCG specializes in representing biomedical technologies and therapeutics before the federal government and associated stakeholders. Our client successes involve for-profit and non-profit entities in areas of funding, research and public policy. We identify and target novel funding opportunities, synergies between client technology and federal/private needs, and policy issues that affect life sciences companies. Our expertise provides our clients an advantage over competitors in the federal and non-federal funding market. Since 2003, our team has helped clients secure nearly $1B in non-dilutive funding and services. Led by Stephen Conafay, TCG is a team of engineers, scientists, and policy experts, as well as former industry executives and federal staff, who offer a wealth of scientific and policy expertise in issues relevant to the life sciences and biotechnology industry. Applying this collective expertise, we have an intimate understanding of the non-dilutive funding landscape, healthcare and innovation policy, federal government needs and priorities, and commercial/institutional partnering opportunities. Our strength lies in putting this knowledge, and our familiarity with the science behind our clients’ technology, to work for our clients. Through our team‐based approach, we are able to deliver fully integrated government relations strategies that enable our clients to achieve greater success.